# STRO (Sutro Biopharma, Inc.) - SEC EDGAR Financial Statements

> Sutro Biopharma, Inc. reported $45.11M in revenue and a net loss of $155.3M for the trailing twelve months ended September 30, 2026 (down 6.1% year over year), with a -265.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/STRO
- Markdown: https://convexityos.com/fundamentals/STRO.md
- SEC CIK: 0001382101
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:46 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001382101&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $45.11M | -6.1% YoY |
| Operating Income | TTM | -$119.5M | -265.0% margin |
| Net Income | TTM | -$155.3M | -344.2% net margin |
| Diluted EPS | TTM | -$9.36 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $142.2M | Total debt: $9.70M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $102.5M | $62.04M | $153.7M | $67.77M | $61.88M | $42.72M | $42.74M | $38.42M | $51.74M | $59.73M |
| Research & Development | $166.4M | $252.0M | $180.4M | $137.2M | $104.4M | $76.96M | $65.61M | $54.26M | $54.64M | $43.55M |
| Total Operating Expenses | $260.9M | $300.5M | $243.0M | $196.7M | $160.4M | $113.8M | $98.20M | $75.64M | $71.01M | $58.37M |
| **Operating Income** | -$158.4M | -$238.5M | -$89.28M | -$128.9M | -$98.52M | -$71.06M | -$55.47M | -$37.22M | -$19.27M | $1.36M |
| **EBITDA** | -$151.0M | -$231.2M | -$82.46M | -$123.3M | -$93.68M | -$66.76M | -$50.69M | -$32.68M | -$14.28M | $7.03M |
| Interest Expense | -- | -- | $1.30M | $2.40M | $2.60M | $2.30M | $1.10M | $1.62M | $612K | $0 |
| Income Before Tax | -$191.2M | -$225.1M | -$88.60M | -$116.7M | -$105.5M | -$32.02M | -- | -- | -- | -- |
| Income Tax Expense | -$93K | $2.36M | $18.19M | $2.50M | $0 | $103K | $0 | $0 | $0 | -- |
| **Net Income** | -$191.1M | -$227.5M | -$106.8M | -$119.2M | -$105.5M | -$32.13M | -$119.2M | -$35.32M | -$19.69M | $1.70M |
| Basic EPS | -$22.49 | -$29.40 | -$17.80 | -$23.50 | -$22.90 | -$9.90 | -$24.30 | -$61.30 | -$439.50 | $0.00 |
| **Diluted EPS** | -$22.49 | -$29.40 | -$17.80 | -$23.50 | -$22.90 | -$9.90 | -$24.30 | -$61.30 | -$439.50 | $0.00 |
| Basic Shares Outstanding | 8.5M | 7.7M | 6.0M | 5.1M | 4.6M | 3.3M | 2.3M | 575.9K | 44.8K | 40.8K |
| Diluted Shares Outstanding | 8.5M | 7.7M | 6.0M | 5.1M | 4.6M | 3.3M | 2.3M | 575.9K | 44.8K | 40.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.10M | $9.84M | $14.52M | $11.65M | $9.69M | $63.74M | $17.40M | $14.81M |
| Research & Development | $23.50M | $31.70M | $36.55M | $36.64M | $39.85M | $38.33M | $51.60M | $71.04M |
| Total Operating Expenses | $31.05M | $39.73M | $44.18M | $49.70M | $58.15M | $67.09M | $85.91M | $80.07M |
| **Operating Income** | -$21.96M | -$29.89M | -$29.66M | -$38.05M | -$48.46M | -$3.35M | -$68.51M | -$65.26M |
| **EBITDA** | -$20.71M | -$28.63M | -$28.38M | -$36.42M | -$46.56M | -$1.45M | -$66.61M | -$63.39M |
| Income Before Tax | -$31.49M | -$38.53M | -$38.50M | -$46.84M | -$56.86M | -$11.52M | -$75.96M | -$70.09M |
| Income Tax Expense | $0 | $1.0K | -$15K | -$82K | $0 | -$18K | $7.0K | -- |
| **Net Income** | -$31.49M | -$38.53M | -$38.48M | -$46.76M | -$56.86M | -$11.50M | -$75.97M | -$72.44M |
| Basic EPS | -$1.90 | -$2.33 | -$2.94 | -- | -$6.66 | -$1.35 | -$9.08 | -- |
| **Diluted EPS** | -$1.90 | -$2.33 | -$2.94 | -- | -$6.66 | -$1.35 | -$9.08 | -- |
| Basic Shares Outstanding | 16.6M | 16.6M | 13.1M | -- | 8.5M | 8.5M | 8.4M | -- |
| Diluted Shares Outstanding | 16.6M | 16.6M | 13.1M | -- | 8.5M | 8.5M | 8.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $58.13M | $190.3M | $69.27M | $47.25M | $30.41M | $206.2M | $4.96M | $125.3M | $22.02M |
| Short-Term Investments | $83.30M | $126.6M | $264.4M | $255.1M | $130.3M | $120.3M | $112.9M | $79.19M | -- |
| **Cash & Short-Term Investments** | $141.4M | $316.9M | $333.7M | $302.3M | $160.8M | $326.5M | $117.9M | $204.5M | $22.02M |
| Accounts Receivable, Net | $3.98M | $8.62M | $36.08M | $7.12M | $12.45M | $5.56M | $6.30M | $2.49M | $1.62M |
| **Total Current Assets** | $150.9M | $343.3M | $421.5M | $353.2M | $218.5M | $378.2M | $128.6M | $209.9M | $25.63M |
| Property, Plant & Equipment, Net | $10.65M | $18.19M | $21.94M | $24.62M | $22.55M | $12.94M | $9.63M | $10.93M | $14.00M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $68.78M | $0 | $15.61M | $0 | -- |
| Other Non-Current Assets | $495K | $7.17M | $3.57M | $1.85M | $1.66M | $2.12M | $2.54M | $2.24M | $1.13M |
| **Total Non-Current Assets** | $22.90M | $43.90M | $49.19M | $53.79M | $122.9M | $15.93M | $27.80M | $13.19M | $15.14M |
| **Total Assets** | $173.8M | $387.2M | $470.7M | $406.9M | $341.4M | $394.1M | $156.4M | $223.1M | $40.77M |
| Accounts Payable | $7.57M | $10.47M | $9.44M | $4.80M | $6.01M | $5.54M | $5.58M | $3.06M | $2.90M |
| Short-Term Debt | -- | -- | $4.06M | $12.50M | $9.38M | -- | $1.00M | $4.72M | $14.56M |
| Deferred Revenue (Current) | $10.56M | $69.78M | $20.67M | $16.76M | $5.50M | $14.60M | $19.46M | $21.57M | $10.71M |
| Other Current Liabilities | $2.91M | $4.01M | $3.90M | $3.08M | $2.75M | $627K | $901K | $847K | $143K |
| **Total Current Liabilities** | $75.13M | $131.9M | $93.75M | $66.55M | $41.74M | $29.60M | $32.97M | $36.42M | $31.96M |
| Long-Term Debt | -- | -- | $0 | $3.77M | $15.74M | $24.55M | $8.88M | $10.00M | -- |
| Deferred Revenue (Non-Current) | $2.03M | $12.54M | $53.38M | $89.89M | -- | $6.10M | $16.20M | $44.60M | $13.16M |
| Other Non-Current Liabilities | $1.69M | $1.69M | $1.69M | $119K | $146K | $481K | $134K | $102K | $14K |
| **Total Non-Current Liabilities** | $231.1M | $210.7M | $227.3M | $123.3M | $47.11M | $32.47M | $25.61M | $55.18M | $15.31M |
| **Total Liabilities** | $306.3M | $342.6M | $321.1M | $189.9M | $88.84M | $62.06M | $58.58M | $91.60M | $47.27M |
| **Total Debt (incl. Leases)** | $15.67M | $23.15M | $33.63M | $50.43M | $57.37M | $24.55M | $9.88M | $14.72M | $14.56M |
| Common Stock | $9.0K | $8.0K | $61K | $58K | $46K | $46K | $23K | $23K | -- |
| Retained Earnings | -$978.0M | -$786.9M | -$559.4M | -$452.6M | -$333.4M | -$227.9M | -$195.7M | -$150.3M | -$115.0M |
| Accumulated Other Comp. Income | $19K | $39K | $21K | -$618K | -$314K | $129K | $165K | -$47K | -- |
| **Total Stockholders' Equity** | -$132.5M | $44.60M | $149.6M | $217.0M | $252.6M | $332.0M | $97.79M | $131.5M | -$109.0M |
| Total Equity | -$132.5M | $44.60M | $149.6M | $217.0M | $252.6M | $332.0M | $97.79M | $131.5M | -$109.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $46.85M | $54.34M | $73.68M | $58.13M | $65.93M | $64.03M | $106.2M | $190.3M |
| Short-Term Investments | $95.33M | $110.0M | $128.9M | $83.30M | $101.7M | $141.1M | $142.7M | $126.6M |
| **Cash & Short-Term Investments** | $142.2M | $164.3M | $202.6M | $141.4M | $167.6M | $205.1M | $249.0M | $316.9M |
| Accounts Receivable, Net | $12.81M | $5.80M | $12.48M | $3.98M | $3.92M | $8.00M | $13.56M | $8.62M |
| **Total Current Assets** | $159.5M | $175.6M | $221.0M | $150.9M | $182.1M | $231.6M | $287.4M | $343.3M |
| Property, Plant & Equipment, Net | $7.13M | $8.36M | $9.36M | $10.65M | $13.35M | $14.98M | $16.80M | $18.19M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $1.98M | $1.13M | $1.09M | $495K | $0 | $50K | $85K | $7.17M |
| **Total Non-Current Assets** | $17.15M | $18.82M | $21.02M | $22.90M | $27.55M | $30.73M | $34.02M | $43.90M |
| **Total Assets** | $176.6M | $194.5M | $242.0M | $173.8M | $209.7M | $262.4M | $321.4M | $387.2M |
| Accounts Payable | $2.84M | $3.36M | $5.49M | $7.57M | $7.03M | $4.31M | $8.18M | $10.47M |
| Deferred Revenue (Current) | $8.27M | $6.46M | $9.40M | $10.56M | $8.98M | $11.96M | $68.98M | $69.78M |
| Other Current Liabilities | $2.64M | $2.73M | $3.03M | $2.91M | $15.79M | $17.83M | $14.17M | $4.01M |
| **Total Current Liabilities** | $54.31M | $52.90M | $70.81M | $75.13M | $71.89M | $74.25M | $133.0M | $131.9M |
| Deferred Revenue (Non-Current) | $1.78M | $0 | $1.23M | $2.03M | $3.76M | $6.91M | $8.57M | $12.54M |
| Other Non-Current Liabilities | $1.69M | $1.69M | $1.69M | $1.69M | $1.69M | $1.69M | $1.69M | $1.69M |
| **Total Non-Current Liabilities** | $254.9M | $244.9M | $238.1M | $231.1M | $225.0M | $220.2M | $214.2M | $210.7M |
| **Total Liabilities** | $309.2M | $297.8M | $308.9M | $306.3M | $296.9M | $294.5M | $347.2M | $342.6M |
| **Total Debt (incl. Leases)** | $9.70M | $10.78M | $13.63M | $15.67M | $17.66M | $19.59M | $21.40M | $23.15M |
| Common Stock | $17K | $17K | $17K | $9.0K | $85K | $85K | $84K | $8.0K |
| Retained Earnings | -$1.09B | -$1.05B | -$1.02B | -$978.0M | -$931.2M | -$874.3M | -$862.8M | -$786.9M |
| Accumulated Other Comp. Income | -$77K | -$58K | -$101K | $19K | $33K | -$13K | -$9.0K | $39K |
| **Total Stockholders' Equity** | -$132.5M | -$103.3M | -$66.89M | -$132.5M | -$87.27M | -$32.11M | -$25.81M | $44.60M |
| Total Equity | -$132.5M | -$103.3M | -$66.89M | -$132.5M | -$87.27M | -$32.11M | -$25.81M | $44.60M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$191.1M | -$227.5M | -$106.8M | -$119.2M | -$105.5M | -$32.13M | -$55.74M | -$35.32M | -$19.69M | $1.70M |
| Depreciation & Amortization | $7.32M | $7.22M | $6.82M | $5.69M | $4.84M | $4.30M | $4.78M | $4.54M | $4.99M | $5.66M |
| Stock-Based Compensation | $14.01M | $24.69M | $24.91M | $26.30M | $23.24M | $11.92M | $10.31M | $2.87M | $1.39M | $968K |
| Change in Receivables | $4.64M | $27.46M | -$28.96M | $5.34M | -$6.89M | $739K | -$3.81M | -$865K | -$1.05M | -$171K |
| Change in Payables | -$2.47M | $706K | $4.81M | -$1.23M | $2.71M | -$1.14M | $2.25M | $209K | -$473K | $874K |
| **Operating Cash Flow** | -$177.2M | -$191.5M | -$111.6M | $3.55M | -$81.68M | -$67.80M | -$65.02M | $12.68M | -$37.07M | -$13.15M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -$1.56M | -$3.32M | -$4.39M |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $11.13M | -$40.39M | -$17.55M |
| Purchases of Investments | -$264.9M | -$461.5M | -$460.3M | -$216.7M | -$248.7M | -$130.7M | -$196.2M | -$81.46M | -$14.22M | -$52.30M |
| **Investing Cash Flow** | $45.01M | $218.5M | -$3.92M | -$35.02M | -$97.31M | $604K | -$51.13M | -$80.19M | $32.60M | $9.59M |
| Common Stock Issued | $0 | $25.00M | $0 | $0 | -- | $251.4M | -$327K | -- | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -$7.0K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $44K | $94.05M | $137.6M | $48.31M | $3.26M | $269.2M | -$4.18M | $170.8M | $14.64M | $177K |
| **Net Change in Cash** | -$132.2M | $121.0M | $22.01M | $16.84M | -$175.7M | $202.0M | -$120.3M | $103.3M | $10.17M | -$3.38M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$31.49M | -$38.53M | -$38.48M | -$46.76M | -$56.86M | -$11.50M | -$75.97M | -$72.44M |
| Depreciation & Amortization | $1.24M | $1.26M | $1.28M | $1.62M | $1.90M | $1.90M | $1.90M | $1.87M |
| Stock-Based Compensation | $2.16M | $2.01M | $1.56M | $1.66M | $1.55M | $5.26M | $5.54M | $5.92M |
| Change in Receivables | -$7.02M | $6.69M | -$8.51M | -$55K | $4.08M | $5.56M | -$4.95M | -$1.96M |
| Change in Payables | -$491K | -$1.69M | -$2.55M | $575K | $2.68M | -$3.85M | -$1.88M | $4.12M |
| **Operating Cash Flow** | -$22.45M | -$38.29M | -$42.26M | -$26.43M | -$38.19M | -$44.72M | -$67.88M | -$71.74M |
| Purchases of Investments | -$32.26M | -$27.85M | -$124.7M | -$4.04M | -$89.94M | -$28.59M | -$142.4M | -$126.0M |
| **Investing Cash Flow** | $14.83M | $19.36M | -$45.26M | $18.70M | $39.99M | $2.58M | -$16.26M | $87.49M |
| **Financing Cash Flow** | $133K | -$418K | $103.1M | -$64K | $102K | -$60K | $66K | -$24K |
| **Net Change in Cash** | -$7.48M | -$19.35M | $15.55M | -$7.80M | $1.90M | -$42.20M | -$84.08M | $15.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -154.5% | -384.3% | -58.1% | -190.3% | -159.2% | -166.3% | -129.8% | -96.9% | -37.2% | 2.3% |
| **Net Profit Margin** | -186.5% | -366.6% | -69.5% | -175.9% | -170.6% | -75.2% | -278.9% | -91.9% | -38.1% | 2.8% |
| Return on Equity (ROE) | -- | -510.0% | -71.4% | -54.9% | -41.8% | -9.7% | -121.9% | -26.8% | -- | -- |
| Return on Assets (ROA) | -109.9% | -58.7% | -22.7% | -29.3% | -30.9% | -8.2% | -76.2% | -15.8% | -48.3% | -- |
| Current Ratio | 2.01x | 2.60x | 4.50x | 5.31x | 5.24x | 12.78x | 3.90x | 5.76x | 0.80x | -- |
| Quick Ratio | 1.94x | 2.47x | 3.94x | 4.65x | 4.15x | 11.22x | 3.77x | 5.68x | 0.74x | -- |
| Debt to Equity | -- | 0.52x | 0.22x | 0.23x | 0.23x | 0.07x | 0.10x | 0.11x | -- | -- |
| **Revenue Growth (YoY)** | +65.2% | -59.6% | +126.8% | +9.5% | +44.8% | 0.0% | +11.2% | -25.7% | -13.4% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -1512.9% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -1256.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -3245.0% | -- | -- | -- | -612.7% | -- | -- | -- |
| 5Y Revenue / Share Growth | -8.0% | -56.9% | -61.7% | -98.8% | -99.1% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -154.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -265.0% | -319.6% | -120.0% | -154.5% | -175.7% | -196.3% | -376.9% | -384.3% |
| **Net Profit Margin** | -344.2% | -395.2% | -154.2% | -186.5% | -205.2% | -199.8% | -369.1% | -366.6% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -510.0% |
| Return on Assets (ROA) | -87.9% | -92.9% | -63.5% | -109.9% | -103.4% | -79.5% | -76.3% | -58.7% |
| Current Ratio | 2.94x | 3.32x | 3.12x | 2.01x | 2.53x | 3.12x | 2.16x | 2.60x |
| Quick Ratio | 2.85x | 3.22x | 3.04x | 1.94x | 2.39x | 2.87x | 1.97x | 2.47x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.52x |
| **Revenue Growth (YoY)** | -6.1% | -84.6% | -16.5% | -21.4% | +13.8% | +148.0% | +33.8% | -87.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -251.2% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -333.2% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -573.0% | -- | -609.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
